Genome reduction strategies to create genetically improved cellular biosynthesis machineries for proteins and other products have been pursued by use of a wide range of bacteria. We reported previously that the novel Bacillus subtilis strain MGB874, which was derived from strain 168 and has a total genomic deletion of 874 kb (20.7%), exhibits enhanced production of recombinant enzymes. However, it was not clear how the genomic reduction resulted in elevated enzyme production. Here we report that deletion of the rocDEF-rocR region, which is involved in arginine degradation, contributes to enhanced enzyme production in strain MGB874. Deletion of the rocDEF-rocR region caused drastic changes in glutamate metabolism, leading to improved cell yields with maintenance of enzyme productivity. Notably, the specific enzyme productivity was higher in the reduced-genome strain, with or without the rocDEF-rocR region, than in wild-type strain 168. The high specific productivity in strain MGB874 is likely attributable to the higher expression levels of the target gene resulting from an increased promoter activity and plasmid copy number. Thus, the combined effects of the improved cell yield by deletion of the rocDEF-rocR region and the increased specific productivity by deletion of another gene(s) or the genomic reduction itself enhanced the production of recombinant enzymes in MGB874. Our findings represent a good starting point for the further improvement of B. subtilis reduced-genome strains as cell factories for the production of heterologous enzymes.Due to recent advances in genetic engineering technology, a variety of useful substances, including enzymes, have been produced industrially by use of microorganisms. To further improve production efficiencies on an industrial scale, several approaches, such as mutational breeding, have been used to generate hyperproducing microbial cells. In addition, strategies for genome reduction (18), which represents a relatively new field in synthetic genomics, have been used with Escherichia coli (25,44) and Bacillus subtilis (3,39,54) to investigate microbial genomic architecture and to improve characteristics relevant to protein production.B. subtilis, a Gram-positive sporiferous bacillus, is an attractive organism for industrial use for a variety of reasons, including its high growth rate, protein secretion ability, and GRAS (generally regarded as safe) status (46, 49). B. subtilis is also one of the best-characterized model microorganisms, by biochemical, genetic, and molecular biological studies. Furthermore, the complete genomic sequence of B. subtilis strain 168 has been determined, facilitating genetic engineering of this industrially useful strain (4, 35).In the 4.2-Mb genome of B. subtilis strain 168, only 271 of the 4,106 identified genes are indispensable for the growth of this organism in rich medium (33). In addition, B. subtilis has numerous genes that are activated only under specific conditions or in response to environmental stresses. Therefore, under controlled cond...